Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases
Annals of Laboratory Medicine · 2025
DOI: 10.3343/alm.2024.0424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2025. Verfasst von Sung-Soo Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Multiple Myeloma, Circulating Tumor DNA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Genetic alterations play a pivotal role in multiple myeloma (MM) development and therapeutic resistance. Traditionally, the genetic profiling of MM requires invasive bone marrow (BM) procedures; however, these procedures are associated with patient discomfort and cannot fully capture the spatial and temporal heterogeneity of the disease. Therefore, we investigated the clinical implications of liquid biopsy using targeted deep sequencing.
Methods
We analyzed the genetic profiles of circulating tumor DNA (ctDNA) by targeted deep sequencing from 102 patients, including those with monoclonal gammopathy of undetermined significance (MGUS, N=7), smoldering MM (N=6), and symptomatic MM (N=89).
Results
The number of ctDNA mutations increased with disease progression from MGUS to MM, with averages of 1.0 mutations in MGUS, 1.8 mutations in smoldering MM, and 1.9 mutations in MM, respectively. Shared mutations between BM and ctDNA were more prevalent in MM (68.9%) than in MGUS (25.0%). RAS/RAF and TP53 mutations were significantly enriched in MM ctDNA. Specific mutations were associated with clinical features in patients with MM: hypercalcemia and TET2 (P =0.006), renal insufficiency and NRAS (P =0.012), paramedullary myeloma and TP53 (P =0.02), and extramedullary myeloma and NRAS (P =0.007). TET2 mutations significantly affected 2-yr progression-free survival (hazard ratio=7.11, P =0.003). Serial ctDNA profiling accurately predicted treatment response in patients with MM.
Conclusions
Our findings highlight the potential of liquid biopsy for understanding MM progression and prognosis utilizing a minimally invasive approach, paving the way for its integration into personalized treatment strategies and real-time disease monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Korea.
- Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Catholic Research Institute for Human Genome Polymorphism, Precision Medicine Research Center, College of Medicine, The Catholic University of Korea; Seoul, Korea.
- Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Sung-Soo Park, Na Yung Kim, Ji-Young Lim, Jung Yeon Lee, Sujin Yun, Yeun-Jun Chung, Seung-Hyun Jung, Chang-Ki Min
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, S. S., Kim, N. Y., Lim, J. Y., Lee, J. Y., Yun, S., Chung, Y. J., Jung, S. H., & Min, C. K. (2025). Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.0424
Vancouver
Park SS, Kim NY, Lim JY, Lee JY, Yun S, Chung YJ, et al. Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases. Annals of Laboratory Medicine. 2025. doi:10.3343/alm.2024.0424
BibTeX
@article{Park2025,
author = {Park, Sung-Soo and Kim, Na Yung and Lim, Ji-Young and Lee, Jung Yeon and Yun, Sujin and Chung, Yeun-Jun and Jung, Seung-Hyun and Min, Chang-Ki},
title = {Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases},
journal = {Annals of Laboratory Medicine},
year = {2025},
doi = {10.3343/alm.2024.0424}
}
EUVIMED